Hybrid Capture assay

Hybrid Capture assay

Lab medicine A proprietary system used to detect and monitor viral–eg, Chlamydia spp, CMV, HBV, HPV infections. See HBV.
Mentioned in ?
References in periodicals archive ?
These methods perform as well as Hybrid Capture assay, however, with the added benefit of being able to discriminate which HPV subtype is present.
Prevalence of Human Papillomavirus Infection in the Genital Tract Determined by Hybrid Capture Assay.
Detection of Human Papillomavirus DNA by the Hybrid Capture Assay.
Use of a hybrid capture assay of self-collected swabs in rural Uganda for detection of human papilloma virus.
Two such assays are the hybrid capture assay (Digene Corp.
A similar study was conducted with 52 renal transplant recipients using the hybrid capture assay (4).
12-14] In contrast, Chesebro and colleagues,[15] reporting on a young population of women, detected high-risk HPV by Hybrid Capture assay (Digene Diagnostics, Silver Spring, Md) in 80% referred with an LSIL Pap smear report, indicating that misclassification of LSIL at this age is rare.
Presence of human papillomavirus infection determined by hybrid capture assay in cervical lesions in a venezuelan population.
The Hybrid Capture Assay I (HC-I) was first introduced by Digene in 1995.
Toronto), the HPV-DNA test uses the Digene hybrid capture assay to detect the presence of high-risk human papillomavirus infection, which is present in 99% of cervical cancer cases.